Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending December 2012. The report details a specific share repurchase transaction executed on December 7, 2012, pursuant to shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share buyback activity:
- Shares Purchased: 685,000 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,351.5 pence per share; lowest price paid was 1,338.5 pence per share.
- Treasury Holdings: Post-transaction, the Company holds 490,140,427 shares in Treasury (9.08% of total issued share capital).
- Total Voting Rights: Including unsettled purchases, Treasury holdings represent 10.03% of current total voting rights.
- Shares in Issue: 4,907,038,096 shares (excluding Treasury shares).
Material Changes
The filing does not report material changes to the Company's financial position, operations, or results compared to prior periods. The primary change noted is the reduction in outstanding shares due to the repurchase of 685,000 shares and the subsequent increase in Treasury stock holdings.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a compliance disclosure confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules regarding share ownership notifications.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (490,140,427) against the Company's latest annual report.
- Confirm the calculation of total voting rights (10.03% held in Treasury) for disclosure threshold assessments.
- Check the price paid per share (1,338.5 to 1,351.5 pence) against market trading data for December 7, 2012.
- Note that this filing does not contain operational or financial performance data; refer to Form 20-F for full financial results.